The JSE tracked firmer global markets on Tuesday, as optimism over a possible coronavirus vaccine lifted sentiment, with investors looking past simmering US-China trade tension.

On Monday, US biotech firm Novavax said it had started the first human study of its experimental coronavirus vaccine. The firm said it expects initial results on safety and immune responses in July.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now